Diabetes Weight Loss Drugs Could Lead to Blindness But Lower Cancer Rates
Ozempic and other diabetes weight loss drugs have soared in popularity in recent years, with more than 15 million adults in the U.S. taking a GLP-1 agonist. The drugs are designed to treat type 2 diabetes but successfully treat obesity, with the average patient losing…